141750-63-2: Pitavastatin Lactone
Pitavastatin developed 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, which is approved for the treatment of hyperlipidemia.
Additional information on CAS 141750-63-2
Catalogue No.
VL4830004
CAS No.
141750-63-2
Molecular Formula
C25H22FNO3
Molecular Weight
403.45
Parent drug
Pitavastatin
IUPAC Name
(4R, 6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-4-hydroxytetrahydro-2H-pyran-2-one
Synonyms
(4R, 6S)-6-[(1E)-2-[2-(Cyclopropyl-d5)-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-one; [4R-[4?, 6?(E)]]-6-[2-[2-(Cyclopropyl-d5)-4-
References
Sci-Hub, Pharmacokinetic Properties of Single- and Multiple-Dose Pitavastatin Calcium Tablets in Healthy Chinese Volunteers. Current Therapeutic Research, 77, 52–57, 10.1016/j.curtheres.2015.02.001. (2015). Sci-Hub.se. https://sci-hub.se/https://doi.org/10.1016/j.curtheres.2015.02.001
Status
In-stock
